<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1993 (6) TMI 221 - CEGAT, NEW DELHI</title>
    <link>https://www.taxtmi.com/caselaws?id=107417</link>
    <description>Classification of PARAMINOL turned on whether its nature, literature and use placed it in Chapter 30 as a medicament or in Chapter 33 as a beauty or skin-care preparation. Chapter Note 1(d) to Chapter 30 excludes Chapter 33 preparations even if they have therapeutic or prophylactic properties, while Chapter Note 2 to Chapter 33 requires the literature, packing label and other indications to be considered. Although the product literature described PARAMINOL as a sun screen and sun tan preventive preparation, the Tribunal followed Nicholas Laboratories and treated the product&#039;s overall profile as medicinal. It was therefore classified under sub-heading 3003.19 in favour of the assessee.</description>
    <language>en-us</language>
    <pubDate>Tue, 29 Jun 1993 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 22 Mar 2012 12:59:21 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=144434" rel="self" type="application/rss+xml"/>
    <item>
      <title>1993 (6) TMI 221 - CEGAT, NEW DELHI</title>
      <link>https://www.taxtmi.com/caselaws?id=107417</link>
      <description>Classification of PARAMINOL turned on whether its nature, literature and use placed it in Chapter 30 as a medicament or in Chapter 33 as a beauty or skin-care preparation. Chapter Note 1(d) to Chapter 30 excludes Chapter 33 preparations even if they have therapeutic or prophylactic properties, while Chapter Note 2 to Chapter 33 requires the literature, packing label and other indications to be considered. Although the product literature described PARAMINOL as a sun screen and sun tan preventive preparation, the Tribunal followed Nicholas Laboratories and treated the product&#039;s overall profile as medicinal. It was therefore classified under sub-heading 3003.19 in favour of the assessee.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Tue, 29 Jun 1993 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=107417</guid>
    </item>
  </channel>
</rss>